The aim of the present study was to test if the methylation level of the CpG sites situated in regulatory regions of ARHGAP22, CDK2AP1, CHML, NCOR2, SLC23A2 and RPL9 that correlated with SMA severity. Here, SLC23A2 is linked to proximal spinal muscular atrophy.